Literature DB >> 17366328

Phospholipidosis in nonclinical toxicity studies.

Brian R Berridge, Linda A Chatman, Marielle Odin, Albert Eric Schultze, Patricia E Losco, James T Meehan, Terry Peters, Steven L Vonderfecht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17366328     DOI： 10.1080/01926230701196414

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN： 0192-6233            Impact factor:   1.902


× No keyword cloud information.
  5 in total

1.  Detection of phospholipidosis induction: a cell-based assay in high-throughput and high-content format.

Authors:  Sampada A Shahane; Ruili Huang; David Gerhold; Ulrich Baxa; Christopher P Austin; Menghang Xia
Journal:  J Biomol Screen       Date:  2013-09-03

2.  An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo.

Authors:  Thomas V Galassi; Prakrit V Jena; Janki Shah; Geyou Ao; Elizabeth Molitor; Yaron Bram; Angela Frankel; Jiwoon Park; Jose Jessurun; Daniel S Ory; Adriana Haimovitz-Friedman; Daniel Roxbury; Jeetain Mittal; Ming Zheng; Robert E Schwartz; Daniel A Heller
Journal:  Sci Transl Med       Date:  2018-10-03       Impact factor: 17.956

3.  Imported bugs, not beasts: extensively drug-resistant tuberculosis and acute kidney injury.

Authors:  Caroline Bell; Kassiani Skordilis; Fouad Al-Baaj; Andrew Bentall
Journal:  Clin Kidney J       Date:  2014-10-04

Review 4.  Repurposing drugs as COVID-19 therapies: A toxicity evaluation.

Authors:  Deborah K Ngan; Tuan Xu; Menghang Xia; Wei Zheng; Ruili Huang
Journal:  Drug Discov Today       Date:  2022-04-06       Impact factor: 8.369

5.  Identification of drugs inducing phospholipidosis by novel in vitro data.

Authors:  Markus Muehlbacher; Philipp Tripal; Florian Roas; Johannes Kornhuber
Journal:  ChemMedChem       Date:  2012-09-03       Impact factor: 3.466
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.